Why do SGLT2 Inhibitors Act as Cardio-renal Protective even in Non-diabetics?

2021 ◽  
Vol 52 (6) ◽  
pp. 157-164
Author(s):  
Satoru KURIYAMA ◽  
Kei MATSUMOTO ◽  
Maki HIRAO ◽  
Otoya MIHO
Keyword(s):  
Sglt2 Inhibitors

Abstract #208: SGLT2 Inhibitors in Ketoacidosis: The Culprit or an Innocent Bystander?

2016 ◽  
Vol 22 ◽  
pp. 33
Author(s):  
Gaurav Bhalla ◽  
Naveen Kakumanu ◽  
Preethi Krishnan ◽  
Saleh Aldasouqi
Keyword(s):  
Sglt2 Inhibitors ◽  
Innocent Bystander

SGLT2 Inhibitors Suppress Alpha-Adrenergic Tone and Morning Elevation of Plasma Glucose Levels

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1667-P
Author(s):  
KEISHI YAMAUCHI
Keyword(s):  
Plasma Glucose ◽  
Sglt2 Inhibitors ◽  
Glucose Levels

Comparative Cardiovascular Efficacy of SGLT2 Inhibitors, DPP-4 Inhibitors, and GLP-1 Agonists—A Network Meta-analysis

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 427-P
Author(s):  
ALISTAIR J. RODDICK ◽  
SEAN ZHENG
Keyword(s):  
Meta Analysis ◽  
Sglt2 Inhibitors

2354-PUB: Estimating Improvement of TGF Mechanism from Changes of Urinary Glucose and Sodium Excretion by SGLT2 Inhibitors

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2354-PUB
Author(s):  
CHIZURU WATANABE ◽  
YASUMICHI MORI
Keyword(s):  
Sodium Excretion ◽  
Sglt2 Inhibitors ◽  
Urinary Glucose

2350-PUB: Renoprotective Effects of SGLT2 Inhibitors in Japanese Real-World Clinical Practice

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2350-PUB
Author(s):  
TAKAHIRO TOSAKI ◽  
SHIORI TOGA SATO ◽  
MASAKI KONDO ◽  
YUICHIRO YAMADA ◽  
AKEMI INAGAKI ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Real World ◽  
Sglt2 Inhibitors

1110-P: Effect of Raised Alanine Transaminase (ALT) Levels on HbA1c in the Association of British Clinical Diabetologists (ABCD) Nationwide Audits of SGLT2 Inhibitors (SGLT2i)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1110-P
Author(s):  
HARSHAL DESHMUKH ◽  
ALEX BICKERTON ◽  
SUZANNE M. PHILLIPS ◽  
ALISON EVANS ◽  
RAJEEV P. RAGHAVAN ◽  
...  
Keyword(s):  
Alanine Transaminase ◽  
Sglt2 Inhibitors

2340-PUB: Success of Online CME at Improving the Clinical Knowledge and Confidence in Using SGLT1/SGLT2 Inhibitors in T1D Management

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2340-PUB
Author(s):  
AMY LARKIN ◽  
MICHAEL LACOUTURE ◽  
ANNE LE
Keyword(s):  
Sglt2 Inhibitors ◽  
Clinical Knowledge
Sign in / Sign up

Export Citation Format

Share Document